Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Genentech, Inc. (NY: )
N/A   UNCHANGED
Last Price  /  Updated:   /  Add to My Watchlist      
View: Quote News
Press releases about Genentech, Inc.
 
< Previous 1 2 3 4 5 6 7 8 9 Next >
A Company and Industry Analysis of North America's Biotechnology Sectors: Understand the Regulatory Environment, Current Breakthroughs & the Market Outlook
October 10, 2008
from Business Wire News Releases
Register Your Company Now for the 2009 IR Global Rankings
October 07, 2008
from PR Newswire
Phase III Study Showed Rituxan in Combination with Chemotherapy Improved Progression-Free Survival in Patients with Relapsed Chronic Lymphocytic Leukemia
October 07, 2008
Study is Second Positive Phase III Trial of Rituxan Plus Chemotherapy in Most Common Adult Leukemia Read More
from Business Wire News Releases
Genentech and OSI Pharmaceuticals Announce Topline Results from Phase III Study Evaluating the Combination of Avastin and Tarceva as Second-Line Treatment for Advanced Non-Small Cell Lung Cancer
October 06, 2008
from Business Wire News Releases
Beacon Equity Issues Technical Trade Alerts on Recent Analyst Upgrades: DISH, DNA, RT, LEA, IRM, ERES
October 03, 2008
from PR Newswire
Genentech, GlycArt and Roche Enter into Collaboration Agreement for Potential Cancer Therapy
October 03, 2008
from Business Wire News Releases
Genentech Issues Dear Healthcare Provider Letter Regarding a Reported Case of PML in a Raptiva Patient
October 02, 2008
from Business Wire News Releases
BellwetherReport.com Analyst Opinions on DNA, BJS, APC and S
October 02, 2008
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by The Bellwether Report. Read More
from Marketwired News Releases
Genentech Announces October 14 Webcast of Financial and Other Business Results
September 23, 2008
from Business Wire News Releases
Seven Summits Research Releases Alerts on INTC, AXP, DNA, DD, and SBUX
September 16, 2008
from PR Newswire
Genentech Announces Vice President Appointment in Research
September 10, 2008
from Business Wire News Releases
Zacks Analyst Interview Highlights: Genentech, ImClone Systems, Bristol-Myers Squibb and Celgene
September 02, 2008
from Business Wire News Releases
BeaconEquity.com Issues Technical Trade Alerts on BioPharmaceutical Stocks: CEGE, AMLN, DNA, GENZ, AMGN, GILD
August 29, 2008
from PR Newswire
BeaconEquity.com Issues Trade Alerts on Biotechnology Stocks: ELN, PFE, AMGN, DNA, BIIB, GILD
August 18, 2008
from PR Newswire
Genentech Special Committee of Independent Directors Responds to Roche Proposal
August 13, 2008
from Business Wire News Releases
Zacks Bull and Bear of the Day Highlights: Genentech, Comerica, Consolidated Edison, Aetna and Dr. Pepper Snapple
August 13, 2008
from Business Wire News Releases
Zacks Analyst Interview Highlights: Genentech, Biogen Idec, Gilead, Celgene and Pfizer
August 01, 2008
from Business Wire News Releases
Genentech Forms Special Committee of Independent Directors to Review Roche Proposal
July 24, 2008
from Business Wire News Releases
Cohen, Milstein, Hausfeld & Toll, P.L.L.C. Files Lawsuit Concerning Genentech Buyout
July 23, 2008
from Business Wire News Releases
BellwetherReport.com Analyst Report on BAC, DNA, TSM and SGP
July 21, 2008
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by The Bellwether Report. Read More
from Marketwired News Releases
Genentech Announces Receipt of Proposal From Roche
July 21, 2008
from Business Wire News Releases
Roche Makes Offer to Acquire All Outstanding Shares of Genentech for US$89.00 Per Share in Cash
July 21, 2008
from PR Newswire
Zacks Analyst Blog Highlights: Toyota Motor Corp., Priceline.com Inc., Acergy S.A., Genentech, Inc. and Infosys Technologies, Ltd.
July 17, 2008
from Business Wire News Releases
Audit Integrity Publishes List of 30 Companies Most Likely to be Sued by Shareholders
July 16, 2008
Company Announces Upgraded Model to Predict Shareholder Lawsuits Read More
from Business Wire News Releases
Zacks Bull and Bear of the Day Highlights: Genentech, Primus Guaranty, Power Integrations, Unibanco and Amdocs
July 16, 2008
from Business Wire News Releases
Genentech Announces Second Quarter 2008 Results
July 14, 2008
from Business Wire News Releases
Seven Summits Research Releases Comments on GOOG, DNA, EBAY, NUE and RS
July 14, 2008
from PR Newswire
Zacks Analyst Blog Highlights: Sangamo Biosciences, Dow AgroSciences, Sigma-Aldrich, Genentech and Progressive Corp.
July 14, 2008
from Business Wire News Releases
Zacks.com featured expert Kevin Matras highlights: Genentech, DaVita and Somanetics
July 03, 2008
from Business Wire News Releases
VLST Corporation Appoints Internationally Recognized Researcher Paul J. Carter, Ph.D. as Chief Scientific Officer
July 02, 2008
from Business Wire News Releases
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here